<--- Back to Details
First PageDocument Content
Pharmacology / Clinical pharmacology / Therapeutics / United States Public Health Service / Center for Drug Evaluation and Research / Genomic Medicine Institute / Dermatologic and Ophthalmic Drugs Advisory Committee / Food and Drug Administration / Pharmaceutical sciences / Clinical research
Pharmacology
Clinical pharmacology
Therapeutics
United States Public Health Service
Center for Drug Evaluation and Research
Genomic Medicine Institute
Dermatologic and Ophthalmic Drugs Advisory Committee
Food and Drug Administration
Pharmaceutical sciences
Clinical research

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 34,44 KB

Share Document on Facebook

Similar Documents

CENTER FOR DRUG EVALUATION AND RESEARCH DRUG SAFETY PRIORITIES 2017

DocID: 1ueGS - View Document

CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 208573Orig1s000 SUMMARY REVIEW

DocID: 1t19G - View Document

CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 022526Orig1s000 SUMMARY REVIEW

DocID: 1sZi5 - View Document

MEMORANDUM DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCH

DocID: 1sPXO - View Document

Abstract # 2639 Enhanced (Q)SAR Models for Prediction Rodent Carcinogenicity Naomi L. Kruhlak1, Dongyu Guo1, Kevin P. Cross2, Lidiya Stavitskaya1 FDA Center for Drug Evaluation and Research (CDER), 10903 New Hampshire A

DocID: 1swgc - View Document